USPTO serial 79180543
MEDICODOSE SYSTEMS 3C SOLUTION COMPLIANCE COUNTERFEIT CLINICAL TRIALS
Reviewed by CopyMark Law Group
Reg. 5116462Status 404
- Filing date
- Status date
- Registration date
- Jan 10, 2017
- Examiner
- ROSSMAN, WILLIAM M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEDICODOSE SYSTEMS 3C SOLUTION COMPLIANCE COUNTERFEIT CLINICAL TRIALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Leonard
Michael J. Leonard Fox Rothschild LLP997 Lenox Drive, Bldg. 3Lawrenceville, NJ 08648-2311UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Veterinary products and medicines, namely, Anti-infective products for the treatment of infection diseases and conditions; dietetic substances for medical use, namely, dietetic sugar for medical use, chemical preparations for pharmaceutical or medical use, namely, the antiseptic preparations and disinfectants for hygiene purposes | SECTION 71 - CANCELLED | — |
| 009 | Scientific apparatuses and instruments for recording and processing information and programs for computers, namely, data processors; monitors for monitoring and tracking the administration of medicines, namely, electronic and computer apparatus in the nature of embedded firmware for monitoring, tracking and recording the administration of medicines; ; data processing equipment and Computer software for use in database management, integrated circuit cards as smart cards; electronic equipment for compilation of medical data by means of wired or wireless transfer of information relating to packaging of medicine intended for personal computers or other data processing equipment, namely, smart phones, computer software platform; electronic reading units, namely, scanners and readers ; Interfaces for computers; computer software for use with packaging equipped with electronic data storage, data storage units and/or display of data, namely, data related to medication intake dosing histories ; software for processing data compiled from packaging with electronic memory and data storage units; ; electronic devices for the detection of counterfeiting, namely, pharmaceutical packaging containing embedded software; integrated circuit cards as smart cards, detection labels and multi-way data recording; scanners and readers for reading and downloading data recorded by circuit cards or identification tags by near field communication (NFC) and radio frequency Identification; computer software for integrated circuit cards smart cards, sensing tags and related scanners and readers for reading and scanning pharmaceutical packaging; software for receiving, retrieval and/or display of data analysis events, in particular in connection with diagnostic and medical information | SECTION 71 - CANCELLED | — |
| 016 | Packaging for pharmaceutical and healthcare products in the nature of cardboard, cardboard and plastic materials combined namely polyethylene and or aluminum, or plastic, including packaging fitted with electronic memory, data storage units and data display units; polyethylene or aluminum for packaging including plastic flexible packaging films used with electronic data storage and data display units, namely, cardboard and plastic bags, sachets, boxes and blister packs; Paper board or paper for the packaging of pharmaceutical products and medicines; Secondary packaging in the nature of cardboard boxes, blister packs for pharmaceutical preparations and medicines in paper and plastic; plastic materials for packaging namely, thermoformed pharmaceutical grade plastic in the nature of plastic bags, containers and film for packaging made of Polypropylene, Polyvinylchloride, Polychlorotrifluoroethylene, Cyclic olefin copolymers, Cyclic olefin polymers and Ethylene-Vinyl Alcohol; products made from the aforesaid materials, namely, blister packs for use as medicines packaging | SECTION 71 - CANCELLED | — |
| 020 | Containers plastic for packaging; boxes and containers of plastic for packaging of pharmaceutical preparations and medicines, including containers with electronic data storage, data storage units and/or display of data; non-metallic containers for packaging medicines that help a patient follow a medical treatment, collect data on the contents of the medicines in the container and communicate with a remote server; plastic packaging containers combined with polyethylene with addition of aluminum and plastic | SECTION 71 - CANCELLED | — |
| 021 | Pill boxes, not included in other classes for personal use; medicine dispensers, namely, solid form medicines dispensers, for pharmaceutical or household purposes not included in other classes; pill boxes for personal use | SECTION 71 - CANCELLED | — |
| 035 | Market research and analysis in the field of pharmaceuticals; promotion of goods and communication services for the pharmaceutical industry in the nature of wired or wireless electronic monitoring and digital mobile networks applied to telemedicine and eHealth care services through dedicated websites and databases; Pharmaceutical business evaluation of information from data tracking use of medication and electronic questionnaires relating to medication intake and effects of medicines through data compilation, preparation of clinical reports relating thereto; analysis of market statistics, compiling information from these statistics and reports containing such information into dedicated databases; computerized file management; commercial information and marketing for third parties, namely, pharmaceutical industry | SECTION 71 - CANCELLED | — |
| 038 | electronic data transmission for using voice services, SMS short message services and data over local and global computer networks; providing multiple-user access to on-line electronic bulletin boards for transmission of messages among computer users relating to medical matters; providing access to a website, namely, the internet that enables users to log on into the website to create information and reports on health, well-being; providing access to web sites for internet users to create technology, annotate, manage and/or utilize information relating to health and well-being; providing access in the nature of, transmission of information data for monitoring and follow-up on medicine intake and reports from electronic questionnaires related to clinical outcomes over a computer network; communications by computer terminals or by fiber-optic networks; radio or telephone communications, mobile radio-telephony services; on-line or telephone reminder services on taking and renewing medication; provision of on-line forums related to clinical indications and medicines; providing access to databases in the medical field; electronic bulletin board services; providing internet users with access rights to dedicated medical databases and web site to create, annotate, manage and/or use data relating to their health, compliance monitoring and detecting counterfeit medicines; providing electronic transmission of patient medical information via the internet; Computer aided transmission of medical information recorded in a database; Computer aided transmission of expert medical reports via electronic means, web site or email | SECTION 71 - CANCELLED | — |
| 044 | Consulting relating to medical monitoring of the consumption of various medicines; medical information services, namely, information concerning medication intake, medication dosage, allergic sensitivity, medication interactions, clinic appointments and renewing prescriptions, intended for patients and provided by means of alerts and interactive monitoring through telephone, email, SMS, website and mobile applications; medical advisory and consultancy services in the field of health; medical advice relating to the best way to ensure medicine is taken correctly and on time; medical information services in the field of health for third parties | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MEDICODOSE SYSTEMS
- Other trademarks owned by MEDICODOSE SYSTEMS
- Other trademarks owned by MEDICODOSE SYSTEMS
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 020
- Other trademarks in Class 021
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 044
- Similar marks named MEDICODOSE SYSTEMS 3C SOLUTION COMPLIANCE COUNTERFEIT CLINICAL TRIALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 12, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 12, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 18, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 18, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 21, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 3, 2024 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 2, 2024 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Mar 21, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 21, 2023 | C71T | CANCELLED SECTION 71 | — |
| Jan 10, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 8, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 12, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 11, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Apr 10, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 16, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 10, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 9, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 25, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 25, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 5, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 5, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 5, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 20, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 26, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 13, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 13, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 13, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 20, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 20, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 20, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 13, 2016 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 22, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 22, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 21, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 20, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 15, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 14, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |